000			01489 a2200433 4500
005			20250512231817.0
264		0	_c19830119
008			198301s 0 0 eng d
022			_a0277-9730
024	7		_a10.1097/00006454-198205000-00006 _2doi
040			_aNLM _beng _cNLM
100	1		_aNelson, J D
245	0	0	_aCefuroxime therapy for pneumonia in infants and children. _h[electronic resource]
260			_bPediatric infectious disease _c
300			_a159-63 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aCefuroxime _xadverse effects
650	0	4	_aCephalosporins _xtherapeutic use
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDrug Evaluation
650	0	4	_aEosinophilia _xchemically induced
650	0	4	_aFemale
650	0	4	_aHaemophilus Infections _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aKinetics
650	0	4	_aMale
650	0	4	_aMeningococcal Infections _xdrug therapy
650	0	4	_aPneumonia _xdrug therapy
650	0	4	_aPneumonia, Pneumococcal _xdrug therapy
650	0	4	_aPneumonia, Staphylococcal _xdrug therapy
650	0	4	_aStreptococcal Infections _xdrug therapy
650	0	4	_aStreptococcus pyogenes
700	1		_aKusmiesz, H
700	1		_aShelton, S
773	0		_tPediatric infectious disease _gvol. 1 _gno. 3 _gp. 159-63
856	4	0	_uhttps://doi.org/10.1097/00006454-198205000-00006 _zAvailable from publisher's website
999			_c6755197 _d6755197